Capricor跳涨,因研究显示deramiocel的长期疗效(CAPR:NASDAQ)

· seekingalpha.com

Capricor (CAPR) 因新的 deramiocel HOPE-3 24个月杜氏肌营养不良症数据而飙升,该数据在11月FDA决定前公布。

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

If you have an ad-blocker enabled you may be blocked from ...


More AI market news · Market heatmap · StrategyVerse · Quant Research · WOBR.AI